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Abstract 
BACKGROUND: One step melanoma surgery is a new surgical approach by which specific groups of patients 
with cutaneous melanoma may be operated only by or within a single surgical session. Until now, the Bulgarian 
Society for Dermatologic Surgery (BULSDS) has presented models of clinical behaviour, in which preoperative 
measurement of tumour thickness in combination with echographic measurement of the locoregional lymph nodes 
could lead to the conduct of the so-called one-step melanoma surgery. Although this one step surgery currently 
does not fit in the recommended guidelines, it ensures compliance of the recommended boundaries of operational 
security while saving patients a repeated excision and relieves the healthcare institutions or the patients 
themselves financially. 
CASE REPORT: We at this moment present another case from the Bulgarian Society for Dermatologic Surgery 
(BULSDS) of one step melanoma surgery with a perfect end result, where the tumour thickness was not 
preoperatively determined by high-frequency echography. Preoperative assessment of tumour thickness was 
performed based on the clinical picture and dermatoscopy. The histologically established tumour thickness was 
identical to the preoperative assessment, i.e. <1 mm. Removal of the melanocytic lesion was performed with 
operational security field of 1cm in all directions, where, as a rule, no further removal of the draining lymph nodes 
is required. 
CONCLUSION: Оne step melanoma surgery has two significant advantages: 1) it saves a re-excision in certain 
groups of patients, which in turn is 2) significantly more favourable from a financial point of view. Its applicability in 
the appropriate groups of patients and the postoperative (although in a limited number of patients) results 
achieved indicate the need to optimise the current algorithms and direct them individually to each patient. 
Guidelines may not and should not be unified or set strict limits given the fact that they show a significant level of 
variability themselves regarding some key moments in the initial surgical treatment of melanoma. More than 10% 
of the primary melanoma cases refer to thin melanomas, and dermatoscopy and clinics are a sufficient method of 
optimising the planned surgical excision. 
 
 
 
 
 
Introduction 
 
Worldwide, melanoma surgery goes through 
the so-called guidelines [1]. One step melanoma 
surgery is a new, innovative approach that is still very 
little discussed in medical circles [2]. It applies to 
specific groups of patients with cutaneous melanomas 
and very clearly demonstrates the need for individual 
preoperative assessment of each clinical case [2]. 
Through it (based on the experience and individual 
assessment of clinical, dermatoscopic and 
ultrasonographic images of lesions and locoregional 
lymph nodes), an optimal diagnostic evaluation is 
achieved, as well as a subsequent adequate 
treatment of cutaneous melanoma [3]. As a major 
advantage of this method, we may point out the basic 
fact that the appropriate patient groups are “spared” 
from the unnecessary, in some cases, repeated 
surgical intervention [4]. 
We at this moment present another case from 
the Bulgarian Society of Dermatological Surgery 
(BULSDS) of a patient with psoriasis with cutaneous 
melanoma localised in the area of regio abdominalis 
Case Report 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
1086                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
dextra. He underwent one step melanoma surgery 
technique (without initial echographic measurement of 
the tumour thickness), other than the established 
guidelines for treatment of malignant melanoma, with 
a perfect end result. The applicability of this type of 
surgery according to the individual characteristics of 
each patient, as well as the need to optimise the 
current guidelines, is currently under discussion. 
 
 
Case Report 
 
A 45-years-old man is presented in good 
general status and concomitant hypertension 
controlled with Aspirin 100 mg (0-0-1) and 
Irbesartan/Hydrochlorothiazide 150 mg/12.5 mg (1-0-
0). No family history data is available. The patient was 
first hospitalised in the clinic for a few months 
worsening of the clinically diagnosed psoriasis 
vulgaris. The disease was diagnosed 20 years ago 
and has not been histologically verified. 
During the dermatological examination, it was 
found that the pathological changes involved the skin 
of the capillitium, back and gluteal area, represented 
by erythemosquamous papules, which in some places 
merged into plaques. Also, there was evidence of 
maceration and mycotic infection in the inguinal area. 
In the regio abdominalis dextra, a hyperpigmented 
macula with uneven pigmentation and uneven edges, 
which existed for many years, was observed (Figure 
1a, 1b). Clinically and dermatoscopically, this finding 
met the requirements for a malignant melanocytic 
lesion. 
 
Figure 1: 1a, 1b) Clinical picture of primary cutaneous melanoma 
located in regio abdominalis dextra. Lesion with uneven 
pigmentation; 1c, 1d) Outlining the 1 cm operational security 
boundaries in all directions, preoperative finding; 1e) Intraoperative 
picture of the lesion removed by elliptical excision; 1d) 
Postoperative clinical picture of surgical defect closed by single 
interrupted sutures 
 
During the hospitalisation some examinations 
were performed, where the paraclinical results were 
within the normal range, and the panoramic image of 
the teeth showed evidence of periodontitis chronic 
granulomatosa 4/5. The rest of the instrumental 
examinations showed no evidence of abnormal 
values. 
Selective ultraviolet therapy with gradual dose 
escalation was initiated. Topical therapy included 10% 
salicylic oil, 10% salicylic ointment and cooling cream. 
Histology confirmed that it was psoriasis vulgaris. It 
was recommended to treat the dental focal infection in 
outpatient conditions and discontinue Aspirin and 
Hydrochlorothiazide therapy (as possible triggers of 
psoriasis). After consultation with a cardiologist, 
Valsartan 160 mg x 1/day therapy was given. For the 
mycotic infection in the inguinal area, Fluconazole 200 
mg x 1/day was administered i.v. Systemically for 3 
days, and Clotrimazole cream x 2/day was topically 
administered. 
During the hospitalisation, the pigment lesion, 
localised in regio abdominalis dextra, suspected for 
malignant melanoma, was surgically removed. 
Radical removal was performed under local 
anaesthesia. Based on the clinical and dermatoscopic 
evidence of the lesion, the surgery was performed 
with an operational security field of 1cm in all 
directions (Figure 1c, 1d, 1e). This was followed by a 
closure of the resulting defect with stretch plaster 
(Figure 1f). The histological examination confirmed 
the diagnosis: Superficial spreading malignant 
melanoma. Clark level II, Breslow thickness below 1 
mm, no ulceration, low mitotic activity, well-expressed 
lymphocyte stromal reaction, no evidence of 
spontaneous regression, clear resection lines (p 
T1aR0). The staging was performed, according to 
which it was found to be Stage I (T1aN0M0). 
 
 
Discussion 
 
Malignant melanoma is a diagnosis, which 
diagnostics and treatment make clinicians think of the 
progress of medicine and whether we tend to be 
flexible and innovative [1]. Currently, the American 
Joint Committee of Cancer recommendations for 
surgical treatment of primary melanoma is based on 
Breslow thickness and include resection of 0.5 to 1 cm 
for melanoma in situ; however, 1.0 cm is also the 
recommended resection area for melanomas between 
1.0 mm to 2 mm? 
And according to the recommendation table, 
this area varies or may vary between 1-2 cm for 
melanomas with a thickness between 1.01-2.00 mm? 
Two cm is also the recommended area for 
treatment of melanomas with a thickness of 2.01-4 
mm [1] [5]. For melanomas with thickness over 4 mm, 
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resection areas of more than 2 cm in all directions are 
not recommended [5]. 
If we are guided by the current guidelines, 
treatment of melanocytic lesions should start with 
resection with surgical security margins of 0.4-0.5 cm 
in all directions, followed by postoperative 
measurement of the tumour thickness and mandatory 
re-excision planning within short-term deadlines [4]. 
Depending on the already established tumour 
thickness, an assessment should be made at a 
subsequent or later stage as to the need of re-
excision with or without removal of draining lymph 
nodes [4]. The question arises inevitably whether it 
would be appropriate to place the various patients 
under a common denominator or to individualise the 
therapy, to be innovative and flexible in our decisions? 
Whether in the modern world of technology, guided to 
a great extent by the so-called “artificial intellect”, it is 
better not to act mechanically, or in other words, 
according to preset algorithms and guidelines, but to 
think and treat each patient separately and 
individually? Due to this circumstance, after having 
observed dozens of patients with melanomas in 
various phases, we have concluded that the 
guidelines (in their current version) are not the optimal 
solution for treatment of melanomas. 
Between 1977 and 1980, the idea of excision 
was adopted for treatment of malignant melanomas, 
depending on the anatomical features of the area, i.e. 
such that allows for primary closure of the surgical 
defect [6]. It varied between 1 and 5 cm even for thin 
melanomas [7]. From the remoteness of the tumour 
tissue from the histologically established resection 
margins (histologically), this method should be more 
accurate and reliable. In their current version, the 
guidelines for treatment of melanoma require only an 
operational security field, which should only be 
observed clinically and not histologically. It is this very 
fact that contains a great contradiction and 
illogicalness. 
Over time, the change in the clinician’s 
thinking has led to optimisation of the 
recommendations, as well as their gradual change 
and update. However, they do not give a specific 
answer to the question why there are again variations 
in the centimetres of the operational security field (0.5-
1 cm for melanoma in situ, 1-2 cm for the thickness of 
1 to 2 mm) and often the free interpretation of the 
guidelines could be reached [1]. What is it that 
requires these variations in tumours with thickness up 
to 2 mm? Why is there no exact categorisation of 
patients’ subgroups according to certain resection 
boundaries!? It is unclear what is it that requires the 
variability of these boundaries in thin to medium-thick 
tumours (find a reference). 
It is precisely this that requires guidelines to 
be redefined and modernised so that they become as 
personalised as possible. One step melanoma 
surgery is a new approach that allows us to go 
beyond the traditional and help the patient as 
adequately as possible, not to take into consideration 
the set boundaries. To support early personalisation, 
which is extremely promising, simple, reliable and 
easy to apply? 
The main diagnostic steps that may be used 
preoperatively for suspected pigmented or pigment 
lesions are 1) clinical examination, 2) dermatoscopy, 
3) biopsy and histological examination, 4) 
measurement of tumour thickness by high-frequency 
ultrasonography, 5) echography and biopsy of lymph 
nodes [3] [8]. 
Tumour thickness in malignant melanomas is, 
in fact, the main indicator determining the action plan, 
the choice of surgical boundaries, the re-excision, the 
additional determination of a draining lymph node and 
the possible lymph dissection [9]. For the patient 
presented by us, the decision for an initial excision 
with an operational security field of 1cm in all 
directions was taken entirely based on 1) the clinical 
experience accumulated over the years, and 2) the 
dermatoscopic finding, which undoubtedly indicated 
melanoma with tumour thickness < 1 mm. The 
subsequent histological examination of the removed 
lesion confirmed the initial diagnosis of malignant 
melanoma with a thickness of less than 1mm, without 
ulcerations, without increased mitotic activity or 
angiolymphatic invasion. This clinical case is an 
example of how both diagnostic determination and 
subsequent treatment are achieved in a single step. 
Although it does not meet the recommendations 
based on European and American guidelines, one 
step melanoma surgery ensures complete removal of 
melanoma, meanwhile taking into account the 
operational security for the respective tumour 
thickness required or recommended by the guidelines 
[3]. The difference is that the intervention is only one. 
Thus, the desired result is achieved within one instead 
of two operational sessions. This leads to another 
important difference, i.e. optimisation of the financial 
coverage of patients or healthcare institutions. The 
method is only applicable to a limited number of 
patients (the method without preoperative 
echographic measurement of the tumour thickness). 
The question remains, as the guideline authors would 
say: “Is it worth changing the guidelines, given that 
these changes will not benefit a large number of 
patients?” The logical answer would be: “Regardless 
of the postulates of these guidelines, an increasingly 
small number of colleagues are guided by them while 
achieving optimal outcomes for their patients. That is, 
the guidelines are disregarded and become 
unnecessary, at least regarding the primary treatment 
of melanomas!” 
Preoperative high-frequency ultrasound 
diagnostics in cases of thin and medium-thick, as well 
as thick primary melanocytic lesions, would be 
extremely useful for determining the operational 
security boundaries, the indications for lymph node 
biopsy, and most importantly, the need for re-excision 
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[9]. However, based on the case presented by us, it 
should be concluded that ultrasonographic 
measurement of tumour thickness is not mandatory 
(in certain groups of patients) (given that it is not even 
mentioned in the commonly accepted guidelines for 
treatment of melanoma). Various studies suggest that 
the tumour thickness measured by ultrasonography 
corresponds to a very high degree to the histologically 
established postoperative Breslow thickness [2] [3] [8] 
[9]. This means that its application (tumour thickness 
measured by echography) may lead again to 
avoidance of re-excision and performance of one 
stage melanoma surgery for patients with melanomas 
of various tumour thickness [10]. That is, it is a 
possible addition to the diagnosis of melanomas but is 
not obligatory. Choosing an optimal approach is 
clearly in the hands of the clinician. 
In thin melanomas with clear clinical and 
dermatoscopic evidence, dermatoscopic and clinical 
data on melanoma may be crucial. The clinician 
should have an individual conversation with the 
patient within which he/she should provide detailed 
information on the one-step model of melanoma 
surgery, its advantages and possible disadvantages. 
After a signed informed preoperative consent, the 
procedure should be performed as quickly as 
possible. 
Melanomas referred to in panel 2 (Figure 2a, 
2b, 2c, 2d) show a tendency to infiltrative growth and 
may not be subject to the innovative method of one 
step melanoma treatment, i.e. without measurement 
of the tumour thickness by echograph. In such cases, 
the decision for one step surgery based on clinical 
and dermatoscopic findings should be defined as 
high-risk, unreasonable, or rather, a wrong step. In 
these cases, if we consider the possibility of treatment 
according to the one stage melanoma surgery 
method, an initial measurement of tumour thickness 
should be made by ultrasonography and additionally, 
by echography of the lymph nodes. Depending on the 
evidence obtained and the available findings, the 
approach to the patients should also be varied: 1) for 
melanomas from 1 mm to 4 mm, resection should be 
done with an operational security field of 2 cm [11] 
and dissection of draining lymph node (regardless of 
whether the node is echographically enlarged) [1] [12] 
for an established tumour thickness above 4 mm- 
again a resection with an operational security field of 2 
cm in all directions, and it should be remembered that 
in the event of thickness above 4 mm, there are other 
two treatment suboptions and at the same time 
staging of melanoma, namely: 2.1) if there are no 
enlarged lymph nodes, 2 cm resection is sufficient, 
together with control/instrumental examinations every 
two months, 2.2) in the presence of enlarged lymph 
nodes, it is recommended that they will be removed 
and examined for the BRAF V600 mutation [13], 
followed by computer tomography scan (CT) with 
contrast or PET scan, the latter at least two months 
postoperatively. In fact, BRAF typing and identification 
of mutations in the BRAF gene helps determine the 
direction of treatment for patients with malignant 
melanoma [14]. Depending on the number and 
localisation of the existing (or additional metastasis), 
treatment should be individualised. Some units 
recommend metastasectomy and monitoring for 
recurrences, which should be tested in turn for BRAF 
V600, but at a later stage. Other units recommend 
starting an adjuvant Interferon treatment or 
vaccination, although patients are surgically “cleared” 
of metastasis/metastases. 
 
Figure 2: 2a, 2b) Clinical view of melanoma showing uneven 
pigmentation and uneven edges located in the epigastrium; 2c, 2d) 
Clinical picture of intense black-coloured cutaneous melanoma 
located in the forehead area 
 
And MEK inhibitors therapy has been shown 
to significantly improve survival in patients with 
mutations in these genes [14]. In turn, CT/PET scan 
images help to better stage melanomas and detect 
metastases [15]. CT has a sensitivity of about 60% in 
the detection of systemic metastases [15]. The right 
approach to the patients should be optimised, and 
perhaps the solution is to find a balance between the 
guidelines and one step melanoma surgery. In other 
words, it is a matter of a point of view or mutual 
compromise. 
In patient number 4 (Figure 3a, 3b) there is 
clinical and dermatoscopic evidence of melanoma 
indicating that it is a tumour with a thickness of more 
than 2 mm. From what has been said so far, if the 
thickness is above 1mm and less than 4mm, the 
draining lymph nodes must be removed and 
examined. Monitoring of the locoregional finding after 
an initial excision should not be advisable. 
Determining a draining lymph node in such cases is 
highly recommended, and if possible, it should be 
done within one surgical session, along with removing 
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the primary melanoma, which would be a more 
sparing solution for the patient (for tumour thickness 
up to 4 mm). 
Lymph nodes dissection depends on the 
echographic evidence of lymph nodes enlargement, 
on the one hand, and whether the tumour thickness is 
more than 4mm, on the other. It is believed that if the 
evidence is indicative of primaries with a measured 
tumour thickness above 4 mm, lymph dissection is not 
so important since then the metastatic spread of a 
tumour (in the event of intact echographic lymph 
nodes) is most likely to have occurred. It is possible, 
however, that the lymph nodes are “bridged”, i.e.: 1) 
there are accessory parallel lymphatic pathways other 
than the flow leading to the draining lymph node; or 2) 
the tumour cells have not been stopped in the draining 
lymph node and have passed through it, or 3) the 
tumour cells have already spread haematologically 
before the involvement of the lymph node. 
 
Figure 3: 3a, 3b) Clinical finding of melanoma located in regio 
abdominalis sinister showing an ulcerated surface; 3c) 
Intraoperative status after oval excision; 3d) Postoperative clinical 
finding 
 
As for our patient number 4 in particular, if the 
echographic tumour thickness is above 4 mm, surgery 
should be performed with a 2 cm operative security 
field in all directions, followed by regular control of the 
locoregional and distant lymph nodes (if these lymph 
nodes are not increased/clinically and echographically 
negative). In other words, we are talking again about 
single surgical intervention. If, however, we do not use 
an individual approach and follow the accepted 
guidelines, this patient should have a primary excision 
with a 0.5 cm field and a second surgical intervention 
with another 1.5 cm field in all directions (as it was 
done). However, in this case, the decision, like in the 
previous cases in Panel 2, should not be only based 
on clinical and dermatoscopic data. Such a decision 
should be defined as a poor assessment, lack of 
experience, a poorly based approach. If a one-step 
model of surgery, deviating from the guidelines, is 
chosen, an echographic measurement of tumour 
thickness and locoregional lymph nodes here is 
recommended. The evidence established in these 
cases should determine the model of clinical 
behaviour, and the applicability of the new 
methodology presented. 
At this stage, malignant melanoma surgery 
should not be considered as completely dependent on 
the accepted guidelines. Any deviation from them 
must still be logically justified and supported by 
appropriate documentation. One step melanoma 
surgery is a bold decision taken by both our 
colleagues and patients and ultimately, the results 
achieved may be defined as more than optimal. 
This good receptivity, accompanied by 
maximum adequacy and precision of echographists, 
dermatoscopists and dermatosurgeons actions 
approaches innovative and deserving particular 
attention. The several different cases of melanoma 
patients described showing that each of them is 
unique and should be interpreted individually, even if it 
means getting out of the comfort and security zone 
provided by the guidelines. One step melanoma 
surgery should be one solution for each of the above 
cases. 
In conclusion, when clinical and 
dermatoscopic data indicate the presence of 
melanoma with a possible predicted tumour thickness 
of less than 1 mm, one step melanoma surgery is a 
very good or optimal solution. 
Whenever we have doubts about our 
assessment of the tumour thickness, based on our 
experience alone (clinical, dermatoscopic), high-
frequency ultrasonography is the option that could 
provide maximum security about the right approach 
and assurance of the clinician’s actions. 
With this clinical case, we present a new 
algorithm or an option to treat cutaneous melanomas 
through one surgical intervention. The guidelines for 
the diagnosis and treatment of melanomas that we 
use should be individually adapted to the various 
groups of patients rather than being used universally 
and often or almost always remain ambiguous. One 
step melanoma surgery relieves the psychological, 
physical and financial burden for the patients and this 
makes it an approach that deserves the attention of 
the medical college. 
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